Synaptic vesicle protein SV2A — Drug Target

All drugs that target Synaptic vesicle protein SV2A — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antiepileptic agent

Marketed (1)

• Keppra · Generic (originally UCB Pharma) · Antiepileptic agent · Metabolic
  Levetiracetam binds to synaptic vesicle protein SV2A, potentially regulating vesicle exocytosis.